In this section

Agenda

Day One - 9/16/2020

  • 1:45 p.m. - Welcome by Ronald Kaplan, PhD, EVP, Research
  • 1:55 p.m. - Overview of Brain Science Institute by Jeremy Amiel Rosenkranz, PhD, Director
  • 2:10 p.m. - “Alzheimer’s Disease – Cure or Prevent?” by Arthur Levine MD, Executive Director of Brain Institute, University of Pittsburgh
  • 2:50 p.m. - Neurodegenerative Diseases Panel
    • Moderator: Grace Stutzmann, PhD, Associate Professor & Director, Center for Neurodegenerative Diseases and Therapeutics, Foundational Sciences and Humanities, Neuroscience Chicago Medical School, School of Graduate and Postdoctoral Studies
    • Robert Marr, PhD, Associate Professor & Assistant Dean for Research, Foundational Sciences and Humanities, Neuroscience Chicago Medical School, School of Graduate and Postdoctoral Studies
    • Sarah Johnson, PhD, Assistant Professor of Neuroscience, Center for Neurodegenerative Diseases and Therapeutics
    • , PhD, Assistant Director, Scientific Affairs at Alzheimer's Drug Discovery Foundation
    • , PhD, Vice President, Medical & Scientific Relations, Alzheimer's Association
    • , PhD, Vice President, Distinguished Research Fellow, Foundational Neuroscience Center, AbbVie
    • , MBA, Global Head, External Engagement Alzheimer's Disease and Neurodegeneration, Eli Lilly and Company
  • 3:50 p.m. - Break
  • 3:55 p.m. - Stress Resilience & Psychiatric Disorders Panel
    • Moderator: Janice Urban, PhD, Director, Center for Neurobiology of Stress Resilience and Psychiatric Disorders; Professor and Discipline Chair, Physiology and Biophysics
    • Joanna Dabrowska, PhD, PharmD, Associate Professor, Foundational Sciences and Humanities, Cellular and Molecular Pharmacology, Neuroscience Chicago Medical School, School of Graduate and Postdoctoral Studies
    • , PsyD, Section Chief, PTSD Programs at Department of Veterans Affairs
    • , PhD, Manager of Research Operations, Aptinyx Inc.
    • , MD, President and CEO, Brain & Behavior Research Foundation
    • , MD, Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Vice Chair for Research and Professor in the Menninger Department of Psychiatry & Behavioral Sciences at Baylor College of Medicine
    • , PhD, PharmD, Global Head, CNS Business Development & Licensing, Boehringer Ingelheim
  • 4:55 p.m. - Closing Remarks by Jeremy Amiel Rosenkranz, PhD, Director
  • 5:00 p.m. - Networking

Day Two - 9/17/2020

  • 1:45 p.m. - Welcome by Archana Chatterjee, MD, PhD, Dean of Chicago Medical School
  • 1:50 p.m. - New Nucleic Acid-based Therapeutic Approaches in Neurological Disease by Michelle Hastings, PhD
  • 2:10 p.m. - Therapeutic Innovation in CNS Disease by Norbert G. Riedel, PhD, President & Chief Executive Officer, Aptinyx
  • 2:50 p.m. - Brain Function, Repair, Regeneration & Genetics Panel
    • Moderator: William Frost, PhD, Director, Stanson Toshok Center for Brain Function and Repair; Professor & Discipline Chair, Cell Biology and Anatomy, Chicago Medical School, School of Graduate and Postdoctoral Studies
    • Michelle Hastings, PhD, Professor & Director, Center for Genetic Diseases, Chicago Medical School, School of Graduate and Postdoctoral Studies
    • , PhD, MS, Chief, Genetics and Epigenetics, and Developmental Neuroscience Research Branch, National Inst. on Drug Abuse at NIH
    • Eun Jung Hwang, PhD, Assistant Professor of Cell Biology and Anatomy, Stanson Toshok Center for Brain Function and Repair
    • , PhD, Executive Director and CEO, Brain Research Foundation 
    • , GPF Foundation Board President
    • , MD, Chief Medical Officer, Exicure
    • , PhD, Associate Director, Translational Science, Aptinyx
  • 3:50 p.m. – Break
  • 3:55 p.m. - Funding Neuroscience Research and New Companies
    • Moderator: , PhD, Executive Editor, BioCentury
    • , PhD, CEO, NeuroLucent
    • , PhD, President, Chief Scientific Officer and Founder, PAX Neuroscience Inc.
    • , PhD, MS, President & CEO, Seurat Therapeutic
    • , PhD, Senior Director, AbbVie Ventures
    • , PhD, CEO Chamishi, CEO Vanqua, Venture Partner OrbiMed
    • , JD, MBA, Partner at Takeda Ventures, Inc.
    • , Senior Analyst, Research Partnerships at The Michael J. Fox Foundation for Parkinson's Research
  • 4:55 p.m. - Closing Remarks by Jeremy Amiel Rosenkranz, PhD, Director
  • 5:00 p.m. – Networking